Purinergic System / / Margarete Bagatini.
Characterized as a common signaling pathway between cells, the purinergic system is capable of modulating physiological and biochemical processes. Composed of signaling molecules, regulatory enzymes, and specific receptors, this organization can modulate several basal pathways of the organism. It is...
Saved in:
VerfasserIn: | |
---|---|
Place / Publishing House: | London : : IntechOpen,, 2022. |
Year of Publication: | 2022 |
Language: | English |
Series: | IntechOpen book series. Biochemistry
|
Physical Description: | 1 online resource (198) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993581452504498 |
---|---|
ctrlnum |
(CKB)5700000000338620 (NjHacI)995700000000338620 (EXLCZ)995700000000338620 |
collection |
bib_alma |
record_format |
marc |
spelling |
Bagatini, Margarete, author. Purinergic System / Margarete Bagatini. London : IntechOpen, 2022. 1 online resource (198) text txt rdacontent computer c rdamedia online resource cr rdacarrier IntechOpen book series. Biochemistry Description based on online resource; title from PDF title page (IntechOpen, viewed March 25, 2023). Characterized as a common signaling pathway between cells, the purinergic system is capable of modulating physiological and biochemical processes. Composed of signaling molecules, regulatory enzymes, and specific receptors, this organization can modulate several basal pathways of the organism. It is understood that purinergic signaling is present in all aspects of immunity and inflammation and studies show that extracellular ATP and its adenosine metabolite are the main mediators of response. These occur since most immune cells express P2 and P1 receptors, which are sensitive to the ATP and adenosine molecules, respectively. This book describes the purinergic system and its correlation with the health and disease process. 1. Purinergic System in Immune Response -- 2. Cross Talk of Purinergic and Immune Signaling: Implication in Inflammatory and Pathogenic Diseases -- 3. Purinergic Signaling in Covid-19 Disease -- 4. Graft-Versus-Host Disease: Pathogenesis and Treatment -- 5. Involvement of the Purinergic System in Cell Death in Models of Retinopathies -- 6. Leukaemia: The Purinergic System and Small Extracellular Vesicles -- 7. Immunomodulatory Effects of a M2-Conditioned Medium (PRS® CK STORM): Theory on the Possible Complex Mechanism of Action through Anti-Inflammatory Modulation of the TLR System and the Purinergic System -- 8. The Potential of the Purinergic System as a Therapeutic Target of Natural Compounds in Cutaneous Melanoma. Cell Biology. 1-80355-783-4 |
language |
English |
format |
eBook |
author |
Bagatini, Margarete, |
spellingShingle |
Bagatini, Margarete, Purinergic System / IntechOpen book series. Biochemistry 1. Purinergic System in Immune Response -- 2. Cross Talk of Purinergic and Immune Signaling: Implication in Inflammatory and Pathogenic Diseases -- 3. Purinergic Signaling in Covid-19 Disease -- 4. Graft-Versus-Host Disease: Pathogenesis and Treatment -- 5. Involvement of the Purinergic System in Cell Death in Models of Retinopathies -- 6. Leukaemia: The Purinergic System and Small Extracellular Vesicles -- 7. Immunomodulatory Effects of a M2-Conditioned Medium (PRS® CK STORM): Theory on the Possible Complex Mechanism of Action through Anti-Inflammatory Modulation of the TLR System and the Purinergic System -- 8. The Potential of the Purinergic System as a Therapeutic Target of Natural Compounds in Cutaneous Melanoma. |
author_facet |
Bagatini, Margarete, |
author_variant |
m b mb |
author_role |
VerfasserIn |
author_sort |
Bagatini, Margarete, |
title |
Purinergic System / |
title_full |
Purinergic System / Margarete Bagatini. |
title_fullStr |
Purinergic System / Margarete Bagatini. |
title_full_unstemmed |
Purinergic System / Margarete Bagatini. |
title_auth |
Purinergic System / |
title_new |
Purinergic System / |
title_sort |
purinergic system / |
series |
IntechOpen book series. Biochemistry |
series2 |
IntechOpen book series. Biochemistry |
publisher |
IntechOpen, |
publishDate |
2022 |
physical |
1 online resource (198) |
contents |
1. Purinergic System in Immune Response -- 2. Cross Talk of Purinergic and Immune Signaling: Implication in Inflammatory and Pathogenic Diseases -- 3. Purinergic Signaling in Covid-19 Disease -- 4. Graft-Versus-Host Disease: Pathogenesis and Treatment -- 5. Involvement of the Purinergic System in Cell Death in Models of Retinopathies -- 6. Leukaemia: The Purinergic System and Small Extracellular Vesicles -- 7. Immunomodulatory Effects of a M2-Conditioned Medium (PRS® CK STORM): Theory on the Possible Complex Mechanism of Action through Anti-Inflammatory Modulation of the TLR System and the Purinergic System -- 8. The Potential of the Purinergic System as a Therapeutic Target of Natural Compounds in Cutaneous Melanoma. |
isbn |
1-80355-784-2 1-80355-783-4 |
callnumber-first |
Q - Science |
callnumber-subject |
QH - Natural History and Biology |
callnumber-label |
QH583 |
callnumber-sort |
QH 3583.15 B343 42022 |
illustrated |
Not Illustrated |
dewey-hundreds |
500 - Science |
dewey-tens |
570 - Life sciences; biology |
dewey-ones |
571 - Physiology & related subjects |
dewey-full |
571.6 |
dewey-sort |
3571.6 |
dewey-raw |
571.6 |
dewey-search |
571.6 |
work_keys_str_mv |
AT bagatinimargarete purinergicsystem |
status_str |
n |
ids_txt_mv |
(CKB)5700000000338620 (NjHacI)995700000000338620 (EXLCZ)995700000000338620 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Purinergic System / |
_version_ |
1764995748742561792 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02469nam a2200325 i 4500</leader><controlfield tag="001">993581452504498</controlfield><controlfield tag="005">20230326221015.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230326s2022 enk o 000 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1-80355-784-2</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.5772/intechopen.94827</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5700000000338620</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)995700000000338620</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995700000000338620</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">QH583.15</subfield><subfield code="b">.B343 2022</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">571.6</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Bagatini, Margarete,</subfield><subfield code="e">author.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Purinergic System /</subfield><subfield code="c">Margarete Bagatini.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London :</subfield><subfield code="b">IntechOpen,</subfield><subfield code="c">2022.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (198)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">IntechOpen book series. Biochemistry</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on online resource; title from PDF title page (IntechOpen, viewed March 25, 2023).</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Characterized as a common signaling pathway between cells, the purinergic system is capable of modulating physiological and biochemical processes. Composed of signaling molecules, regulatory enzymes, and specific receptors, this organization can modulate several basal pathways of the organism. It is understood that purinergic signaling is present in all aspects of immunity and inflammation and studies show that extracellular ATP and its adenosine metabolite are the main mediators of response. These occur since most immune cells express P2 and P1 receptors, which are sensitive to the ATP and adenosine molecules, respectively. This book describes the purinergic system and its correlation with the health and disease process.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">1. Purinergic System in Immune Response -- 2. Cross Talk of Purinergic and Immune Signaling: Implication in Inflammatory and Pathogenic Diseases -- 3. Purinergic Signaling in Covid-19 Disease -- 4. Graft-Versus-Host Disease: Pathogenesis and Treatment -- 5. Involvement of the Purinergic System in Cell Death in Models of Retinopathies -- 6. Leukaemia: The Purinergic System and Small Extracellular Vesicles -- 7. Immunomodulatory Effects of a M2-Conditioned Medium (PRS® CK STORM): Theory on the Possible Complex Mechanism of Action through Anti-Inflammatory Modulation of the TLR System and the Purinergic System -- 8. The Potential of the Purinergic System as a Therapeutic Target of Natural Compounds in Cutaneous Melanoma.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Cell Biology.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">1-80355-783-4</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-04-15 13:10:54 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-12-05 16:10:45 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5343023840004498&Force_direct=true</subfield><subfield code="Z">5343023840004498</subfield><subfield code="8">5343023840004498</subfield></datafield></record></collection> |